Prevalence and predictors of anemia among adult HIV infected patients at the University of Gondar Hospital, Northwest Ethiopia

References

• WHO. ETHIOPIA Update Sheet on HIV/AIDS Programme 2014. ETHIOPIA Update sheet on HIV/AIDS programme 2014; 2015.
   Google Scholar
• Levine AM, Berhane K, Masri-Lavine L, et al. Prevalence and correlates of anemia in a large cohort of HIV-infected women: women’s interagency HIV study. J Acquir Immune Defic Syndr. 2001. doi:10.1097/00042560-200101010-00004
   Web of Science ®Google Scholar
• Ndlovu Z, Chirwa T, Takuva S. Incidence and predictors of recovery from anaemia within an HIV-infected South African cohort, 2004–2010. Pan Afr Med J. 2014. doi:10.11604/pamj.2014.19.114.3600
   Google Scholar
• Assefa M, Abegaz WE, Shewamare A, Medhin G, Belay M. Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia. BMC Hematol. 2015. doi:10.1186/s12878-015-0024-6
   Google Scholar
• Abdissa SG, Fekade D, Feleke Y, Seboxa TDE. Adverse drug reactions associated with antiretroviral treatment among adult Ethiopian patients in a tertiary hospital. Ethiop Med J. 2012;50(2):107–113.22924279
   PubMedGoogle Scholar
• Lartey M, Essel A, Asante-Quarshie A, Kenu E, Ganu V, Neequaye A. Dverse drug reactions to antiretroviral therapy during the early art period at a tertiary hospital in Ghana. Pan Afr Med J. 2014. doi:10.11604/pamj.2014.18.25.3886
   Google Scholar
• Gedefaw L, Yemane T, Sahlemariam Z, Yilma D, Diemert DJ. Anemia and risk factors in HAART Naïve and HAART experienced HIV positive persons in South West Ethiopia: a comparative study. PLoS One. 2013. doi:10.1371/journal.pone.0072202
   Web of Science ®Google Scholar
• Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS. 1999. doi:10.1097/00002030-199905280-00010
   Web of Science ®Google Scholar
• Kerkhoff AD, Wood R, Cobelens FG, Gupta-Wright A, Bekker LG, Lawn SD. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study. BMC Med. 2015. doi:10.1186/s12916-015-0320-9
   Web of Science ®Google Scholar
• Namutebi AMN, Kamya MRK, Byakika-Kibwika P. Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda. Afr Health Sci. 2013;13(4):977–85. doi: 10.4314/ahs.v13i4.17
   Web of Science ®Google Scholar
• Anude CJ, Eze E, Onyegbutulem HC, et al. Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria. BMC Infect Dis. 2013. doi:10.1186/1471-2334-13-113
   Web of Science ®Google Scholar
• Adane A, Desta K, Bezabih A, Gashaye AKD. HIV-associated anaemia before and after initiation of antiretroviral therapy at ART centre of Minilik II Hospital, Addis Ababa, Ethiopia. Ethiop Med J. 2012;50(1):13–21.22519158
   PubMedGoogle Scholar
• Zhou J, Jaquet A, Bissagnene E, et al. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. J Int AIDS Soc. 2012. doi:10.1186/1758-2652-15-5
   Web of Science ®Google Scholar
• Enawgaw B, Alem M, Melku M, Addis Z, Terefe B, Yitayew G. Prevalence and associated risk factors of anemia among HIV infected children attending Gondar University Hospital, Northwest Ethiopia: a cross sectional study. BMC Hematol. 2015. doi:10.1186/s12878-015-0032-6
   Google Scholar
• Mijiti P, Yuexin Z, Min L, Wubuli M, Kejun P, Upur H. Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China. Int J STD AIDS. 2015. doi:10.1177/0956462414531935
   Web of Science ®Google Scholar
• Renouf LS, Sheps S, Hubley A, Pick N, Johansen D, Tyndall MW. The role of diet in predicting: iron deficiency anemia in HIV-positive women. Can J Diet Pract Res. 2012. doi:10.3148/73.3.2012.128
   Web of Science ®Google Scholar
• Akilimali PZ, Kashala-Abotnes E, Musumari PM, et al. Predictors of persistent anaemia in the first year of antiretroviral therapy: a retrospective cohort study from Goma, the Democratic Republic of Congo. PLoS One. 2015. doi:10.1371/journal.pone.0140240
   Web of Science ®Google Scholar
• Kiragga AN, Castelnuovo B, Nakanjako D, Manabe YC. Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. J Int AIDS Soc. 2010. doi:10.1186/1758-2652-13-42
   Web of Science ®Google Scholar
• Johannessen A, Naman E, Gundersen SG, Bruun JN. Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infect Dis. 2011;11:190. doi:10.1186/1471-2334-11-20821745396
   PubMed Web of Science ®Google Scholar
• Ssali F, Stöhr W, Munderi P, et al. Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antivir Ther. 2006;11(6):741–9.
   Web of Science ®Google Scholar
• Curkendall SM, Richardson JT, Emons MF, Fisher AE, Everhard F. Incidence of anaemia among HIV - Infected patients treated with highly active antiretroviral therapy. HIV Med. 2007. doi:10.1111/j.1468-1293.2007.00500.x
   Web of Science ®Google Scholar
• Owiredu WKBA, Quaye L, Amidu N, Addai-Mensah O. Prevalence of anaemia and immunological markers among Ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci. 2011;11(1):2–15.
   Web of Science ®Google Scholar